|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The overall findings suggest that the workbook format was no less effective or acceptable than the validated online format.Significant improvements (avg. improvement; Internet Group vs Workbook Group) in levels of disability (PDI: 16% vs 24%; RMDQ: 12% vs 15%), anxiety (GAD-7: 36% vs 26%), and depression (PHQ-9: 36% vs 36%) were observed in both groups immediately posttreatment.
|
28394850 |
2017 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
In a cross-sectional study, 23 patients with IPF were evaluated using Montreal Cognitive Assessment (MoCA), an instrument for detecting mild cognitive impairments and were screened for OSA through overnight cardiorespiratory polygraphy and for anxiety and depression with three specific scale (Generalized Anxiety Disorder 7-item scale: GAD-7; the Patient Health Questionnaire: PHQ-9; Hospital Anxiety and Depression Scale: HADS).
|
30707735 |
2019 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A binary logistic regression analyses were conducted to test the association between all four ratings in GAD-7 (anxiety) and PHQ-9 (depression) scales subitems as covariates, and migraine vs no headache as the outcome.
|
28324317 |
2017 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this pilot study, nineteen female students participating on a NCAA Division III athletic team (hockey="in-season"; soccer="off-season") were compared for level of fitness (modified Balke test of VO<sub>2</sub> max), salivary IgA levels by immunoassay, anxiety (using a GAD-7 survey), salivary cortisol levels by immunoassay, and numbers of culturable bacteria by growth of CFU/ml on blood agar, mitis salivarius agar and Staphylococcus 110 agar.
|
27932242 |
2017 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Hearing performance was assessed with Freiburg monosyllabic test and Oldenburg inventory (OI); the health-related quality of life was measured with Nijmegen Cochlear Implantation Questionnaire (NCIQ); depressive symptoms with General Depression Scale (ADS-L); stress with Perceived Stress Questionnaire (PSQ) and anxiety with General Anxiety Disorder-7 (GAD-7).
|
30870379 |
2019 |
|
Anxiety
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Data were collected by using a pre-developed questionnaire, consisting of socio-demographic information, comprehensive lifestyle information, and psychological health information including a nine-item scale, the Patient Health Questionnaire-9 (PHQ-9) for assessing the level of depression, and a 7-item scale, the Generalized Anxiety Disorder-7 (GAD-7) for assessing the level of anxiety.
|
31226611 |
2019 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
There were no significant differences between SCP recipients and controls at 6 months postintervention on self-reported cancer and survivorship knowledge, physical functioning, satisfaction with information provision, or self-efficacy or at 12 months on anxiety, cancer-specific distress, depression, or satisfaction with follow-up care.
|
31653679 |
2019 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
The 7-item Generalized Anxiety Disorder Scale (GAD-7) and the 9-item Patient Health Questionnaire (PHQ-9) were used to assess the anxiety and depressive symptoms of the mothers of the autistic children.
|
31393408 |
2019 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A total of 34% reported either a prior diagnosis of depression or scored 10 or greater on the PHQ-8, and 31% reported either a prior diagnosis of anxiety or scored 10 or greater on the GAD-7.
|
30637564 |
2019 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Symptoms of depression and anxiety were measured using the Patient Health Questionnaire (PHQ-9) and the General Anxiety Disorder-7 (GAD-7).
|
29025788 |
2017 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Measures included PHQ-9 (depression), GAD-7 (anxiety) and PCL-C (post-traumatic stress disorder).
|
30591033 |
2018 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients also completed an anxiety screener (GAD-7).
|
29644783 |
2018 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Generalized Anxiety Disorder Scales GAD-7 and GAD-2 are instruments for the assessment of anxiety.
|
28088111 |
2017 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The response rate, as measured by a 50% decrease in scores, for those with initial scores ≥10 was 58.6% for depression (PHQ-9) and 50% for anxiety (GAD-7).
|
28165775 |
2017 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
Test Performance Characteristics of the AIR, GAD-7 and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease.
|
29986152 |
2018 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this single-centre approach, n = 1,000 adolescents will be screened (using PHQ-9 and GAD-7), and adolescents with results indicative of anxiety or depressive symptoms (n = 162) will be advised to seek psychological health care in clusters from treating physicians in specialised outpatient departments.
|
30428891 |
2018 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
PWE from rural West China were evaluated for depression and anxiety with the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E; Chinese version) and the Generalized Anxiety Disorder-7 (GAD-7; Chinese version).
|
30125939 |
2018 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Among 2100 participants (1051 males and 1049 females), 475 (22.6%) were identified with anxiety (scoring 8 points or higher on the GAD-7 scale).
|
30125814 |
2018 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
18.3% of primary caregivers had symptoms of depression (based on PHQ-9 cut-off point of 10 or greater) while 12.7% had symptoms of anxiety (based on GAD-7 cut-off point of 10 or greater).
|
28526049 |
2017 |
|
Anxiety
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Emotional processing theory variables did not predict any anxiety outcomes at posttreatment or follow-up with one exception: Initial fear activation predicted less anxiety at follow-up among youth without GAD.
|
27355694 |
2019 |
|
Anxiety
|
0.100 |
Biomarker
|
disease |
BEFREE |
Item response theory-based linking methods were used to create crosswalk tables that convert scores on the GAD-7 to the TBI-QOL Anxiety metric and scores on the PHQ-9 to the TBI-QOL Depression metric.
|
31498233 |
2019 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Based on ICIQ-OAB scores, patients were dichotomized as having OAB versus LUTS-other, and GAD-7 scores categorized patients as having anxiety.
|
31302716 |
2019 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Of the 36 women who started iCBT, 26 completed all three lessons of treatment (76% adherence rate). iCBT produced moderate to large effect size reductions for anxiety on the GAD-7 (Hedges' g = 0.76) and psychological distress on the Kessler-10 (g = 0.88) that were superior to TAU.
|
30266030 |
2019 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Primary outcome measures will assess anxiety and depressive symptoms using the GAD-7 and PHQ-9, respectively.
|
29499675 |
2018 |
|
Anxiety
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, self-rating questionnaires were used to assess somatic symptom severity (PHQ-15), depression severity (PHQ-9) and anxiety severity (GAD-7).
|
28554368 |
2017 |